12/04/2025 | Press release | Distributed by Public on 12/04/2025 16:28
|
|
|
|
|
|
Delaware
|
|
|
11-3713499
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
|
(I.R.S. Employer
Identification Number)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Large accelerated filer
|
|
|
☐
|
|
|
Accelerated filer
|
|
|
☐
|
|
Non-accelerated filer
|
|
|
☒
|
|
|
Smaller reporting company
|
|
|
☒
|
|
Emerging growth company
|
|
|
☒
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
Item 14.
|
Other Expenses of Issuance and Distribution
|
|
|
|
|
|
|
SEC registration fee
|
|
|
$22,965
|
|
FINRA filing fee
|
|
|
$23,000
|
|
Accounting fees and expenses
|
|
|
*
|
|
Legal fees and expenses
|
|
|
*
|
|
Transfer agent fees and expenses
|
|
|
*
|
|
Trustee fees and expenses
|
|
|
*
|
|
Printing and miscellaneous expenses
|
|
|
*
|
|
Total
|
|
|
$*
|
|
|
|
|
|
|
*
|
These fees cannot be estimated at this time, as they are calculated based on the securities offered and the number of issuances. In accordance with Rule 430B, an estimate of the aggregate expenses in connection with the sale and distribution of the securities being offered will be included in the applicable prospectus supplement
|
|
Item 15.
|
Indemnification of Officers and Directors
|
|
Item 16.
|
Exhibits and Financial Statement Schedules
|
|
|
|
|
|
|
Exhibit Number
|
|
|
Description
of Document
|
|
1.1*
|
|
|
Form of Underwriting Agreement
|
|
|
|
Eleventh Amended and Restated Certificate of Incorporation of Femasys Inc., dated as of June 22, 2021 (filed as Exhibit 3.3 to the Registration Statement on Form S-1/A of the Company (File No. 333-256156), as filed on June 14, 2021, and incorporated by reference herein).
|
|
|
|
|
Amended and Restated Bylaws of Femasys Inc. (filed as Exhibit 3.4 to the Registration Statement on Form S-1 of the Company (File No. 333-256156), as filed on May 14, 2021, and incorporated by reference herein).
|
|
|
|
|
First Amendment to the Amended and Restated Bylaws of Femasys Inc., dated as of March 29, 2023 (filed as Exhibit 3.1 to the Current Report on Form 8-K of the Company (File No. 001-40492), as filed on March 30, 2023, and incorporated by reference herein).
|
|
|
|
|
Form of Common Stock Certificate of Femasys Inc. (filed as Exhibit 4.1 to the Registration Statement on Form S-1 of the Company (File No. 333-256156), as filed on May 14, 2021, and incorporated by reference herein).
|
|
|
4.2*
|
|
|
Form of certificate of designation with respect to any preferred stock issued hereunder and the related form of preferred stock certificate
|
|
|
|
Form of indenture to be entered into between registrant and a trustee acceptable to the registrant.
|
|
|
4.4*
|
|
|
Form of warrant agreement.
|
|
4.5*
|
|
|
Form of warrant certificate.
|
|
4.6*
|
|
|
Form of debt security.
|
|
4.7*
|
|
|
Form of rights certificate.
|
|
4.8*
|
|
|
Form of unit agreement.
|
|
4.9*
|
|
|
Form of unit certificate.
|
|
|
|
Opinion of Dechert LLP.
|
|
|
23.1
|
|
|
Consent of KPMG LLP.
|
|
|
|
Consent of Dechert LLP (included in its Opinion filed as Exhibit 5.1 hereto).
|
|
|
|
|
Powers of Attorney (included on signature page).
|
|
|
25.1***
|
|
|
Statement of Eligibility of Trustee under the Indenture.
|
|
|
|
Filing Fee Table
|
|
|
|
|
|
|
|
*
|
To be filed, if applicable, by amendment or as an exhibit to a document filed under the Securities Exchange Act of 1934, as amended, and incorporated by reference herein.
|
|
**
|
Previously filed
|
|
***
|
To be filed separately pursuant to Section 305(b)(2) of the Trust Indenture Act of 1939, as amended, and the appropriate rules and regulations thereunder.
|
|
Item 17.
|
Undertakings
|
|
(1)
|
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
|
|
(i)
|
To include any prospectus required by Section 10(a)(3) of the Securities Act;
|
|
(ii)
|
To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the
|
|
(iii)
|
To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;
|
|
(2)
|
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
|
|
(3)
|
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
|
|
(4)
|
That, for the purpose of determining liability under the Securities Act to any purchaser:
|
|
(i)
|
Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and
|
|
(ii)
|
Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.
|
|
(5)
|
That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser: (i) any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424; (ii) any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant; (iii) the portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and (iv) any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
|
|
(6)
|
That, for purposes of determining any liability under the Securities Act, each filing of the registrant's annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
|
|
(7)
|
To file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the SEC under Section 305(b)(2) of the Trust Indenture Act.
|
|
|
|
|
|
|||
|
FEMASYS INC.
|
|
|
||||
|
|
|
|
|
|||
|
By:
|
|
|
/s/ Kathy Lee-Sepsick
|
|
|
|
|
|
|
Kathy Lee-Sepsick
|
|
|
||
|
|
|
Chief Executive Officer and President
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name and Signature
|
|
|
Title
|
|
|
Date
|
|
|
|
|
|
|||
|
/s/ Kathy Lee-Sepsick
|
|
|
President and Chief Executive Officer and
Member of the Board of Directors (Principal Executive Officer)
|
|
|
December 4, 2025
|
|
Kathy Lee-Sepsick
|
|
|||||
|
|
|
|
|
|||
|
/s/ Dov Elefant
|
|
|
Chief Financial Officer
(Principal Financial and Accounting Officer)
|
|
|
December 4, 2025
|
|
Dov Elefant
|
|
|||||
|
|
|
|
|
|||
|
*
|
|
|
Director
|
|
|
December 4, 2025
|
|
Charles Larsen
|
|
|||||
|
|
|
|
|
|||
|
*
|
|
|
Director
|
|
|
December 4, 2025
|
|
Alistair Milnes
|
|
|||||
|
|
|
|
|
|||
|
|
|
Director
|
|
|
December 4, 2025
|
|
|
Joshua Silverman
|
|
|||||
|
|
|
|
|
|||
|
*
|
|
|
Director
|
|
|
December 4, 2025
|
|
Edward Uzialko, Jr.
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*By:
|
|
|
/s/ Kathy Lee-Sepsick
|
|
|
|
|
|
|
Kathy Lee-Sepsick
|
|
|
||
|
|
|
Attorney-in-fact
|
|
|
||
|
|
|
|
|
|
|
|